SCHEMBL5952777

SCHEMBL5952777

CCCCCC(=O)c1ccccc1Cl

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.57
HTT P42858 3/20 0.50
ERCC5 P28715 1/20 0.50
FEN1 P39748 1/20 0.50
LMNA P02545 1/20 0.49
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
KMT2A Q03164 1/20 0.49
ATM Q13315 1/20 0.49
CES2 O00748 2/20 0.48
CES1 P23141 2/20 0.48
HSD17B3 P37058 6/20 0.47
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29219464 0.98 HPGD (0.55) HPGDHTTERCC5FEN1LMNA
SCHEMBL6680586 0.95 HPGD (0.58) HPGDHTTERCC5FEN1LMNA
SCHEMBL633349 0.87 ERCC5 (0.55) HPGDHTTERCC5FEN1LMNA
SCHEMBL8161357 0.86 ERCC5 (0.53) HPGDHTTERCC5FEN1ALDH1A1
SCHEMBL23515028 0.84 HDAC3 (0.56) HPGDERCC5FEN1LMNAALDH1A1
SCHEMBL5661990 0.84 ERCC5 (0.51) HPGDERCC5FEN1LMNAALDH1A1
SCHEMBL19757425 0.83 HSD17B3 (0.56) HPGDLMNAMAPTKMT2AHSD17B3
SCHEMBL15979733 0.82 CES2 (0.62) HPGDERCC5FEN1LMNAALDH1A1
SCHEMBL5546417 0.82 ERCC5 (0.50) HPGDERCC5FEN1LMNAALDH1A1
SCHEMBL20508903 0.82 ERCC5 (0.50) HPGDERCC5FEN1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed
WO-2000075094-A2 METHOD FOR PRODUCING A HALOGENATED ACETOPHENONE ISHIHARA SANGYO KAISHA, LTD. (JP) 2000-12-14 WO disclosed
EP-0968158-A1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM Basell Polyolefine GmbH (DE) 2000-01-05 EP disclosed
WO-1998040331-A1 PREPARATION OF PREPARING SUBSTITUTED INDANONES TARGOR GMBH (DE) 1998-09-17 WO disclosed
EP-0542685-A1 3-Aryluracile derivatives and their use against weeds CIBA-GEIGY AG (CH) 1993-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A HPGD 132/4885HTT 4095/4885ERCC5 2128/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 HPGD 159/4885HTT 4113/4885ERCC5 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.